Interestingly, six genes among these (ABCB1, FGF2, CXCR4, IL6, PSMB9, and CLU), as well as UGCG, are known to be highly associated with cancer resistance to platinum-based chemotherapy [35]. This evidence concerns the gene ABCB1 and cancer.